GHGabriel Heymann

Gabriel Heymann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gabriel Heymann has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Ann Nordgren

    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Anna Lindstrand

    Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

    1 shared publication
  • Antonino Alberti

    Unit of Pediatrics &Medical Genetics, IRCCS Associazione Oasi Maria Santissima, Troina, Italy

    1 shared publication
  • Bradley P Coe

    Department of Genome Sciences, University of Washington, Seattle, Washington, USA

    1 shared publication
  • Britt-Marie Anderlid

    Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Christopher Barnett

    South Australian Clinical Genetics Service, SA Pathology (at Women's and Children's Hospital), Adelaide, South Australia, Australia

    1 shared publication

Latest Publications

  • Open Access

    Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains

    by Madeleine R Geisheker, Gabriel Heymann, Tianyun Wang, Bradley P Coe, Tychele N Turner, Holly A F Stessman, Kendra Hoekzema, Malin Kvarnung, Marie Shaw, Kathryn Friend, et al.

    This study characterizes the properties of disease-causing mutations that produce sporadic amino acid replacements in proteins of people with autism and developmental delay. The mutations tend to cluster and reoccur at specific regions important to protein function, highlighting for future follow-up ∼200 candidate genes, many involved in neuronal signaling. Although de novo missense mutations have been predicted to account for more cases of autism than gene-truncating mutations, most research has focused on the latter. We identified the properties of de novo missense mutations in patients with neurodevelopmental disorders (NDDs) and highlight 35 genes with excess missense mutations. Additionally, 40 amino acid sites were recurrently mutated in 36 genes, and targeted sequencing of 20 sites in 17,688 patients with NDD identified 21 new patients with identical missense mutations. One recurrent site substitution (p.A636T) occurs in a glutamate receptor subunit, GRIA1. This same amino acid substitution in the homologous but distinct mouse glutamate receptor subunit Grid2 is associated with Lurcher ataxia. Phenotypic follow-up in five individuals with GRIA1 mutations shows evidence of specific learning disabilities and autism. Overall, we find significant clustering of de novo mutations in 200 genes, highlighting specific functional domains and synaptic candidate genes important in NDD pathology.


  • Open Access

    Inter- and intrasubunit interactions between transmembrane helices in the open state of P2X receptor channels

    by Gabriel Heymann, Jian Dai, Mufeng Li, Shai D. Silberberg, Huan-Xiang Zhou, Kenton J. Swartz

    Significance: The opening of P2X receptor channels by extracellular ATP underlies purinergic signaling in many tissues. Here we use computational and functional approaches to study helix interactions within the transmembrane domain of P2X receptors. Our results suggest that the intersubunit crevices observed in the X-ray structure of detergent-solubilized ATP-bound receptors are nonnative but confirm helix interactions within individual subunits observed in both apo and ATP-bound receptors and identify a hot spot within a narrow internal region where the gating and permeation properties can be readily tuned.